Replies to post #1973 on Arch Therapeutics Inc (ARTH)

[Regis999]

Interesting thoughts. Thank you. Johnson and Johnson for example with say 60% of the market would be easier to get a "foothold" that you describe.

Agree with your external testing for agents added for tissue growth, etc. That is down the line.

If you search Europe for Pressure Ulcers for example you see it is a huge market. Who better qualified to role this out than a major company.

[BonelessCat]

This might help you better understand the protocol and outcomes:
https://clinicaltrials.gov/ct2/show/NCT02704104?term=AC5+arch&rank=1